Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00002493 · ClinicalTrials.gov registry record · Phase 3

Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer

A Phase 3 study of Endometrial Cancer and Psychosocial Effects of Cancer and Its Treatment, sponsored by Gynecologic Oncology Group.

Completed
Registry status
Phase 3
Development phase
20
Study locations

NCT00002493: Completed Phase 3 study of Endometrial Cancer and Psychosocial Effects of Cancer and Its Treatment, sponsored by Gynecologic Oncology Group.

NCT00002493 is a Phase 3 study of Endometrial Cancer and Psychosocial Effects of Cancer and Its Treatment that has completed, run by Gynecologic Oncology Group. The trial reports 20 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00002493, a Phase 3 study of Endometrial Cancer and Psychosocial Effects of Cancer and Its Treatment, has completed, sponsored by Gynecologic Oncology Group.

COMPLETED
Registry status
Phase 3
Development phase
20
Study locations

Study Summary

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known which treatment regimen is more effective for endometrial cancer. PURPOSE: Randomized phase III trial to compare radiation therapy with chemotherapy in treating patients who have advanced endometrial cancer.

Conditions Studied

Endometrial Cancer Psychosocial Effects of Cancer and Its Treatment

Interventions

  • DRUG cisplatin
  • DRUG doxorubicin hydrochloride
  • RADIATION low-LET photon therapy

Study Locations (20)

California

  • USC/Norris Comprehensive Cancer Center - Los Angeles
  • Jonsson Comprehensive Cancer Center, UCLA - Los Angeles
  • Chao Family Comprehensive Cancer Center - Orange
  • Women's Cancer Center - Palo Alto
  • Stanford University Medical Center - Stanford

District of Columbia

  • Vincent T. Lombardi Cancer Research Center, Georgetown University - Washington D.C.
  • Walter Reed Army Medical Center - Washington D.C.

Georgia

  • Emory University Hospital - Atlanta - Atlanta
  • CCOP - Atlanta Regional - Atlanta

Illinois

  • Rush-Presbyterian-St. Luke's Medical Center - Chicago
  • University of Chicago Cancer Research Center - Chicago

Alabama

  • University of Alabama Comprehensive Cancer Center - Birmingham

Arizona

  • CCOP - Greater Phoenix - Phoenix

Colorado

  • University of Colorado Cancer Center - Denver

Florida

  • H. Lee Moffitt Cancer Center and Research Institute - Tampa

Trial Details

FieldValue
Start Date 1992-05
Phase Phase 3
Gynecologic Oncology Group

154 total trials

What the finished NCT00002493 record still lists

NCT00002493 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.

The record links to 2 conditions, with Endometrial Cancer appearing as the primary indexed condition, and to 3 interventions - of which cisplatin is the first listed.

NCT00002493 names 20 study sites across 13 states, led by California, District of Columbia, Georgia.

Frequently Asked Questions

What is clinical trial NCT00002493 about?

NCT00002493 is a clinical study titled "Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer". RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known which treatment regimen is more effective for endometrial cancer. PURPOSE: Randomized phase II...

What is the current status of trial NCT00002493?

This trial is currently completed. It is a Phase 3 study. The study started on 1992-05.

What conditions does trial NCT00002493 study?

This clinical trial studies the following conditions: Endometrial Cancer, Psychosocial Effects of Cancer and Its Treatment.

What interventions are being tested in trial NCT00002493?

The interventions under investigation include: cisplatin (DRUG), doxorubicin hydrochloride (DRUG), low-LET photon therapy (RADIATION).

Who is sponsoring clinical trial NCT00002493?

This trial is sponsored by Gynecologic Oncology Group, which has 154 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00002493 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Colorado, District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Endometrial Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT00002493, the US trial registry maintained by the National Library of Medicine. NCT00002493 (unsized enrollment · wide site footprint · completed) retrieved and formatted by PlainTrial, see methodology.